Endometrial Adenocarcinoma
1 competing product in clinical development for Endometrial Adenocarcinoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ACR-368 + Gemcitabine | Acrivon Therapeutics | Phase 2 | Recruiting | 44 |
1 competing product in clinical development for Endometrial Adenocarcinoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ACR-368 + Gemcitabine | Acrivon Therapeutics | Phase 2 | Recruiting | 44 |